1. p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD (2005) J Biol Chem 280(16): 15649-58
    › Primary publication · 15728187 (PubMed)
  2. Overview: a rare opportunity or just one less reason to be depressed. Blakely RD (2005) Neuron 48(5): 701-2; author reply 705-6
    › Primary publication · 16337900 (PubMed)
  3. Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation. Mason JN, Farmer H, Tomlinson ID, Schwartz JW, Savchenko V, DeFelice LJ, Rosenthal SJ, Blakely RD (2005) J Neurosci Methods 143(1): 3-25
    › Primary publication · 15763132 (PubMed)
  4. Norepinephrine modulates glutamatergic transmission in the bed nucleus of the stria terminalis. Egli RE, Kash TL, Choo K, Savchenko V, Matthews RT, Blakely RD, Winder DG (2005) Neuropsychopharmacology 30(4): 657-68
    › Primary publication · 15602500 (PubMed)
  5. Labeling cell-surface proteins via antibody quantum dot streptavidin conjugates. Mason JN, Tomlinson ID, Rosenthal SJ, Blakely RD (2005) Methods Mol Biol : 35-50
    › Primary publication · 15923673 (PubMed)
  6. Inhibitors of the serotonin transporter protein (SERT): the design and synthesis of biotinylated derivatives of 3-(1,2,3,6-tetrahydro-pyridin-4-yl)-1H-indoles. High-affinity serotonergic ligands for conjugation with quantum dots. Tomlinson ID, Mason JN, Blakely RD, Rosenthal SJ (2005) Bioorg Med Chem Lett 15(23): 5307-10
    › Primary publication · 16183285 (PubMed)
  7. Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. Prasad HC, Zhu CB, McCauley JL, Samuvel DJ, Ramamoorthy S, Shelton RC, Hewlett WA, Sutcliffe JS, Blakely RD (2005) Proc Natl Acad Sci U S A 102(32): 11545-50
    › Primary publication · 16055563 (PubMed) · PMC1183547 (PubMed Central)
  8. Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala. Mazei-Robison MS, Blakely RD (2005) Neuropharmacology 49(6): 737-49
    › Primary publication · 16212992 (PubMed)
  9. Evidence for biphasic effects of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation. Jayanthi LD, Samuvel DJ, Blakely RD, Ramamoorthy S (2005) Mol Pharmacol 67(6): 2077-87
    › Primary publication · 15774771 (PubMed)
  10. Developmental expression of the high affinity choline transporter in cholinergic sympathetic neurons. Guidry G, Willison BD, Blakely RD, Landis SC, Habecker BA (2005) Auton Neurosci 123(1-2): 54-61
    › Primary publication · 16278103 (PubMed) · PMC1407245 (PubMed Central)